AI assistant
LISATA THERAPEUTICS, INC. — Director's Dealing 2015
Jan 21, 2015
34931_dirs_2015-01-21_51f81d92-11ae-4154-ac32-b4ba25c81abd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2015-01-16
Reporting Person: Smith Robin L (Director, Exec. Chairman of the Board)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-01-16 | Common Stock, par value $0.001 per share | A | 39276 | — | Acquired | 329410 | Direct |
| 2015-01-16 | Common Stock, par value $0.001 per share | F | 20117 | $3.48 | Disposed | 309293 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-01-16 | Stock Option (right to purchase) | $3.73 | D | 50000 | Disposed | 2025-01-01 | Common Stock, par value $0.001 per share (50000) | Direct |
Footnotes
F1: On January 16, 2015, the reporting person, Robin L. Smith, M.D., entered into an amendment to her employment agreement, as amended (the "Amendment") with NeoStem, Inc. (the "Company). Pursuant to the terms of the Amendment, the award consists of a grant of 39,276 shares of the Company's common stock, par value $0.001 per share (the "Common Stock"). The award was made pursuant and subject to the terms and conditions of the Company's Amended and Restated 2009 Equity Compensation Plan (the "2009 Plan").
F2: On January 2, 2015, in connection with a January 1, 2015 amendment to her employment agreement, as amended, Dr. Smith was granted an option to purchase 300,000 shares of Common Stock, pursuant and subject to the terms and conditions of the 2009 Plan (the "Option"). Pursuant to the terms of the Amendment, the award described in footnote 1 was made in exchange for the rescission of a portion of the Option, such Option being reduced to an option to purchase 250,000 shares of Common Stock. The award of Common Stock described in footnote 1 has a Black-Scholes value equal to the value of the rescinded portion of the Option.
F3: The Option, as amended, vested as to one-third of the Option shares immediately upon grant, with the remainder of the Option scheduled to vest as to one-third of the Option shares on June 7, 2015 and as to the remaining one-third of the Option shares on December 7, 2015.